Achaogen inc stock

Achaogen, Inc. - AKAOQ - Stock Price Today - Zacks

Mar 27, 2020 · Company Overview ----- Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections. AKAOQ | Achaogen Inc. Stock Price & News - WSJ View the latest Achaogen Inc. (AKAOQ) stock price, news, historical charts, analyst ratings and financial information from WSJ. Achaogen's Bankruptcy Filing, Proposed Sale: What You Need ... Apr 15, 2019 · Nanocap biotech Achaogen Inc (NASDAQ: AKAO) has been pushed to the brink, Split Verdict Chokes Stock. The writing on the wall was clear after Achaogen's lead product candidate Zemdri, or

15 Jun 2016 Achaogen Stock Could Surge to $10 Achaogen (AKAO: Nasdaq) Inc. Some of the reports' issuers have provided, or hope to provide, 

Search | Nasdaq - Nasdaq Stock Market | Stock Quotes ... Yes! I would like to receive Nasdaq communications related to Products, Industry News and Events. You can always change your preferences or unsubscribe and your contact information is covered by Achaogen Inc. (AKAOQ) Stock Message Board - InvestorsHub Mar 27, 2020 · Company Overview ----- Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections. AKAOQ | Achaogen Inc. Stock Price & News - WSJ View the latest Achaogen Inc. (AKAOQ) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Achaogen, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes 

AKAOQ:OTC US Stock Quote - Achaogen Inc - Bloomberg Markets

Achaogen (AKAO) Stock: Now May Be The Time To Get Involved ...

Achaogen, Inc. Announces Results of Auction for ... Achaogen is a biopharmaceutical company passionately committed to the development and commercialization of innovative antibacterial treatments for MDR gram negative infections. Achaogen (AKAO) Stock: Now May Be The Time To Get Involved ... Apr 25, 2019 · Achaogen Inc (NASDAQ: AKAO) is rocketing in the market this today, gaining as much as 62.92%. With no news out, many are wondering what’s going on. However, with no news, that means that anything mentioned as to the current run in value would be speculation. So, I’m … Stock Comparison: Compare Achaogen Inc - Ordinary Shares ... Online Stock Comparison - Compare Achaogen Inc - Ordinary Shares (AKAOQ) to four other stocks with NASDAQ.com's stock comparison tool.

23 Mar 2020 Real-time trade and investing ideas on Achaogen Inc. AKAO from the largest community of traders and investors.

AKAOQ | Achaogen Inc. Profile | MarketWatch Apr 01, 2020 · Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. Achaogen, Inc. - AKAOQ - Stock Price Today - Zacks View Achaogen, Inc. AKAOQ investment & stock information. Get the latest Achaogen, Inc. AKAOQ detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AKAO Stock Quote - Achaogen Inc - Bloomberg Markets Stock analysis for Achaogen Inc (AKAO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Achaogen - AKAO - Stock Price & News | The Motley Fool

Stock analysis for Achaogen Inc (AKAO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get today's Achaogen stock news. We cover the latest Achaogen headlines and breaking news impacting Achaogen stock performance.